RTX owns irreplaceable positions in commercial engines, avionics, and missile defense, but the stock at $174 sits 15% above base-case IV ($151) while the Pratt powder-metal recall still consumes cash. Wait for the pitch.

Plain English

RTX makes jet engines (Pratt), airplane parts and avionics (Collins), and missiles and radars (Raytheon). When an airline or government buys one, they pay the company to fix and upgrade it for thirty years. That is the real money. The trouble: a metal-quality problem in some Pratt engines is costing billions, and the stock costs more than the business is worth today. The business is excellent. The price is not. Wait for it to get cheaper.

Thesis

RTX Corporation is the merged Raytheon Technologies — three businesses bolted together: Collins Aerospace (avionics, interiors, mission systems), Pratt & Whitney (commercial and military jet engines including the GTF and F135), and Raytheon (missile defense, radars, Patriot, AMRAAM, SM-3, SM-6). Together they form one of two Western prime contractors (the other is Lockheed Martin in defense, GE Aerospace in commercial engines) capable of supplying the long-life systems that fly on Airbus A320neo, Boeing 787, F-35, and ground-based air defense.

The compounder thesis rests on three legs. First, a $230B+ backlog (~3.5x revenue) split roughly half commercial and half defense provides multi-year visibility. Second, the installed base of ~12,000 large commercial engines and tens of thousands of fielded radars and missiles drives a high-margin aftermarket annuity that grows for decades after the original sale. Third, the geopolitical regime change post-2022 — Ukraine, Israel/Iran, Pacific deterrence — has pulled forward NATO and allied defense budgets toward replenishment of exactly the products Raytheon makes (Patriot, NASAMS, Stinger, SM-6, AMRAAM, GEM-T).

The scorecard, however, says wait. 10-year average ROIC of 5.6% is sub-cost-of-capital and barely qualifies as 'compounder' arithmetic. P/E TTM of 51x and EV/FCF of 42x are clearly inflated — owner earnings of $8.6B have been suppressed by the Pratt powder-metal recall (multi-billion charge accrued 2023-2025) and customer-concession cash payments still flowing through 2026. Reverse-DCF implied growth of 6.0% is plausible but not cheap.

Base IV is $151 vs. current $174 — Px/IV = 1.15. A Buffett-Munger investor demands a margin of safety, not a premium. The math says: hold/avoid here, accumulate aggressively below $130 (well under base IV with some buffer for execution risk on GTF). This is a quality business at a wrong price.

Moat

RTX has genuine, multi-source competitive advantages, but they are unevenly distributed across the three segments. I assess each.

Pratt & Whitney — intangibles + switching costs (WIDE on installed base, NARROW on new platforms). Once an engine is certified on an airframe and an airline takes delivery, the customer is locked in for 25-30 years through maintenance contracts, parts, and overhaul services. Damodaran's framing on switching costs applies directly [2]: 'the most significant barrier to entry... is the cost to the end-user of switching.' An A320neo operator who chose the GTF cannot swap to CFM LEAP without grounding the fleet, retraining mechanics, restocking spares, and renegotiating every maintenance contract. That is the same dynamic Buffett describes when discussing why Precision Castparts' aerospace components business eventually normalizes despite shocks [1] — these are sticky industrial relationships measured in decades. However, on new aircraft selection (e.g., next-gen narrowbody), Pratt competes head-to-head with CFM (GE/Safran) and Rolls-Royce, and the GTF's powder-metal contamination has demonstrably dented its credibility. The certification moat is real (FAA/EASA airworthiness data packages take 7-10 years and billions to build), but it does not preclude market-share losses on new orders.

Collins Aerospace — intangibles + scale (WIDE). Collins is a quiet monopolist on aircraft interiors, avionics, wheels-and-brakes, ejection seats, and mission systems. Position-by-position, Collins is often sole-source or one of two qualified vendors per platform. Once a 787 ships with Collins flight controls, that line ships Collins flight controls for the program's entire 30-year production run plus aftermarket. This is the closest analogue inside RTX to Buffett's praise of Precision Castparts' aerospace-component franchise [1]: indispensable, certified, hard to displace. The competitor stress test (a $10B challenger, 5 years) fails — certification timelines alone exceed 5 years, and airlines refuse non-OEM parts on safety-critical systems.

Raytheon (defense) — intangibles + cost advantages from scale (WIDE within categories). Raytheon has near-monopoly positions in specific missile categories: Patriot (PAC-3 is Lockheed's, but PAC-2/GEM-T and the launcher/radar are Raytheon), AMRAAM (sole-source air-to-air), SM-3/SM-6 (sole-source ballistic-missile defense), Stinger (sole-source MANPADS being restarted), and Tomahawk (sole-source). Damodaran's caveat about regulated/legal monopolies applies [2] — DoD controls pricing through DCMA audits and cost-plus structures cap excess returns — but the entry barrier (security clearance, ITAR, decades of test data, nuclear-hardened production) is essentially insurmountable. Competitor stress test: even with $10B and 5 years, no new entrant clears the qualification gate.

Pricing power. Mixed. Commercial aftermarket has real pricing power (mid-single-digit annual escalators on overhaul). Defense prime contracts are largely cost-plus or fixed-price-incentive — not a pricing-power business in the Buffett sense. Original-equipment commercial engines are sold below cost; the franchise lives in the aftermarket tail.

Erosion risks. (1) GTF reputational damage if a second contamination event surfaces. (2) Hypersonics and directed-energy weapons disrupting legacy missile categories — Raytheon is competing here but is not the obvious leader. (3) Continuing-resolution defense budget instability or major DoD acquisition reform that recompetes legacy programs. (4) Pratt losing the next-gen narrowbody competition to CFM RISE.

Moat verdict: WIDE. The combined intangibles (certification, security clearance, installed base, sole-source positions) and switching costs (25-year aftermarket annuities) clear the test. ROIC of 5.6% understates true economic moat because GAAP capital is bloated by goodwill from the United Technologies / Raytheon merger — on tangible operating capital, returns are materially higher. But the moat is wide; the price is the problem.

Management

RTX management — CEO Chris Calio (took over from Greg Hayes in May 2024) and CFO Neil Mitchill — inherited a complex post-merger entity and an unforced operational disaster. I grade their five capital-allocation choices in order.

1. Reinvestment in the business. Capex has run $2.5-3.0B/year, roughly aligned with depreciation, plus elevated R&D ($2.7B) and capitalized customer concessions tied to GTF. Reinvestment quality is mixed: the GTF program itself was a heroic engineering bet (geared architecture, 16% better fuel burn) that has paid off commercially — A320neo backlog into the 2030s — but was undermined by a metallurgy quality-control failure in the high-pressure turbine disk, traceable back to powder-metal supplier processes from 2015-2021 that escaped detection. This is exactly the kind of long-tail tail risk Munger warns about: a slow-developing latent defect in a complex system, where the cost of finding it later is multiples of the cost of preventing it. The cash impact is now estimated at $7-8B over 2024-2027.

2. Acquisitions. The 2020 United Technologies / Raytheon merger of equals created scale, diversification, and tax efficiency, but introduced ~$50B of goodwill that depresses reported ROIC. Subsequent tuck-ins have been modest. Divestitures have been disciplined — Collins sold its actuation business (to Safran) and cybersecurity business (to Blackstone), redeploying ~$2B into debt reduction and the GTF fix. The portfolio is tighter post-divestitures, which is what shareholders want.

3. Debt management. Net debt/EBITDA reads as -0.60 in the scorecard — almost certainly a data artifact (gross debt ~$42B; net debt is positive). Investment-grade ratings (A-/Baa1) have been maintained but pressured by GTF cash outflows. Interest coverage is not reported but is healthy on TTM EBITDA of ~$13B against $1.7B interest expense (~7-8x). Debt service is fine; absolute leverage is high but typical for a defense prime.

4. Buybacks. Here is the meaningful concern. RTX executed a $10B accelerated share repurchase in late 2023 at average prices around $80-90. In hindsight that was excellent — stock is now $174. However, share count is up 5.5% over 10 years (per scorecard) — meaning the legacy United Technologies share count plus the Raytheon merger consideration plus stock-based comp have outrun gross buybacks. Net, management has been a dilutor over the cycle, not a compounder. Average P/IV on the ASR was below 1.0x, which is acceptable, but the multi-year scorecard says they have not been good stewards of share count.

5. Dividends. Dividend yield ~2.0% with a long history of annual increases (over 30 years for the legacy United Technologies entity). Payout ratio is reasonable but consumes ~$3.5B/year of FCF that arguably should have funded the GTF fix without leverage drift.

Communication quality. Calio's commentary has been more candid than predecessor Hayes about GTF cost ranges and cash timing. Guidance has been hit/missed in roughly equal proportion. Restructuring charges and 'special items' show up too often — a Munger red flag.

Capital allocator: B-. Solid on divestitures and the well-timed 2023 ASR; poor on long-run share-count discipline and on the quality-control failure that produced the GTF recall. Not best-in-class. Not Lockheed-tier disciplined. But not destructive either.

Industry

Porter's Five Forces on RTX's three segments, then a synthesis.

1. Threat of new entrants — LOW (commercial engines and avionics) to NEGLIGIBLE (defense primes). Certification, ITAR, DoD security clearance, decades of flight-test data, and integration with airframer development cycles create barriers measured in decades and tens of billions of dollars. The last new entrant in Western fighter engines was Pratt 70+ years ago. New radar/missile primes have not entered since the post-Cold-War consolidation of the 1990s. China is building parallel capacity (AVIC, NORINCO) but is structurally locked out of NATO/Five Eyes/Pacific allied procurement. This is one of the most defensible structures in industrial America.

2. Bargaining power of buyers — HIGH on OE, LOW on aftermarket. The U.S. DoD is essentially a monopsony — it dictates margin via DCMA pricing audits, cost-plus structures, and statutorily capped fees on cost-type work. On commercial OE, Boeing and Airbus extract concessions because engine selection drives airframe sales. However, once installed, the aftermarket is a quasi-captive market: airlines must use OEM parts and OEM-licensed MRO shops for safety-critical components. This is where the value pool sits — RTX earns its returns over 25-30 years on each fielded engine and avionics line, not on initial sale.

3. Bargaining power of suppliers — MODERATE. Specialized castings (Precision Castparts is in fact a Berkshire-owned key supplier — see [1] [3]), forgings, semiconductors, rare-earth magnets, and specialty alloys (titanium, nickel superalloys, sometimes from Russian/Chinese sources) introduce supply concentration. The Pratt powder-metal recall traces in part to supplier process drift. Counter-balancing: RTX's scale means it is most suppliers' largest customer. Net moderate.

4. Threat of substitutes — LOW near-term, RISING long-term. No substitute for jet engines on tube-and-wing aircraft this decade. Long-term watch items: hydrogen propulsion, hybrid-electric (Pratt is investing), open-rotor (CFM RISE concept). On the defense side: hypersonics, directed energy, and autonomous swarms could disrupt traditional missile categories. Raytheon is competing in all three but is not unambiguously winning. The substitution risk is real but plays out over 15-25 years, beyond our planning horizon.

5. Rivalry among existing competitors — MODERATE on commercial, LOW on key defense categories. Commercial engines: rational duopoly (Pratt vs. CFM on narrowbody; GE vs. Rolls vs. Pratt on widebody) with decades of disciplined behavior. Defense: most categories are sole-source or two-supplier. The exception is missile defense interceptors, where Lockheed (PAC-3 MSE) directly competes with Raytheon offerings, and emerging non-traditional players (Anduril) are pressuring legacy primes on cost and schedule for select programs.

Value pool location and trajectory. Value is migrating from OE-engine sales (loss-leaders) to aftermarket services (high-margin annuity), and into missile defense replenishment (multi-year tailwind from Ukraine/Israel consumption rates). Both trajectories favor RTX. The risk is a peace dividend or a major defense-budget reform; under any base case, allied defense spending is structurally higher post-2022.

Industry Verdict: Good. Not 'Excellent' — DoD monopsony pricing, OE losses, capital intensity, and the 5.6% 10Y average ROIC keep this short of railroad/payments-tier industry economics. But entry barriers are exceptional and the value pool is migrating in RTX's direction.

Inversion

I am now a short-seller. My job is to make the case that RTX at $174 is a value trap, not a compounder. Here is the strongest version of that argument.

1. The single event that kills this. A second powder-metal-style discovery in a different Pratt engine line — most plausibly the F135 (powering F-35) or a widebody program. The F135 fleet is approaching its first major depot cycle. If a similar contamination cohort surfaces in F135 disks, the U.S. government becomes both customer and adversary: cost-recovery clawbacks, possible suspension of new deliveries, congressional hearings, and a loss of the next major engine competition (NGAP — Next Generation Adaptive Propulsion). One bad metallurgical disclosure in 2026 wipes out 30-40% of the equity value. Probability is not high — call it 10-15% — but the conditional outcome is catastrophic, and the market is currently priced as if it is zero.

2. Why the moat is narrower than bulls think. The 'sole-source defense prime' narrative obscures the fact that defense earns DCMA-capped margins (typically 10-12% on cost-plus, sometimes higher on fixed-price-incentive). This is regulated-utility economics, not Buffett-style pricing power. Damodaran's warning [2] applies directly: 'the competitive advantage that comes from exclusive licensing or a legal monopoly is a mixed blessing... the entity usually preserves the right to control the prices charged and margins earned through regulation.' On commercial engines, the GTF's quality stumble is driving Airbus to push CFM LEAP harder on shared-engine narrowbody decisions; Pratt's win rate on the next decade of orders may compress materially. And Collins' 'sole-source' position on platform-by-platform components doesn't extend to new program decisions — Honeywell, Safran, BAE, and Thales all bid against Collins on next-gen avionics, and the Tier-1 supplier landscape is more competitive than the installed-base narrative suggests.

3. Why management is worse than it appears. Three indictments. (a) Share count up 5.5% over 10 years — they have been net dilutors through the cycle, not compounders, despite a massive ASR. (b) The GTF metallurgy failure occurred under their watch and was not detected by their QA system; the response has been competent but the prevention failed. (c) The 2020 merger was sold on $1B+ of run-rate synergies; the goodwill it added has buried tangible-capital ROIC and the synergy realization has been muddied by the GTF charge such that we cannot independently verify it. New CEO Calio is unproven on capital allocation through a downcycle. The Lockheed comparator — same industry, far better capital discipline — exposes RTX as second-tier on this dimension.

4. What bulls are extrapolating that won't hold. (a) Defense replenishment as a multi-decade tailwind. The Ukraine consumption rate is unsustainable; even if the war continues, U.S./EU industrial capacity is the binding constraint, not order pace. Once Patriot, Stinger, and AMRAAM stockpiles are restored (2027-2029), order rates revert toward maintenance levels. (b) Commercial aerospace 'super-cycle.' Airline orders are extrapolating record-low fleet retirements and pent-up post-COVID demand into 2035 — a recession or fuel-price spike compresses orders within two years. (c) Aftermarket pricing power expanding indefinitely. Airlines (American, United, Delta) have begun forming MRO consortia to drive used-serviceable-material adoption, which directly attacks new-spare margins. (d) GTF cash drag ending in 2027. The customer-concession schedule extends through 2030 in management's own disclosures.

5. Valuation trap (multiple compression / regime change). Today: P/E 51, EV/FCF 42, P/IV 1.15. These are peak-cycle multiples on cyclically-depressed TTM earnings (suppressed by GTF charges). Bulls argue normalized earnings are 50-70% higher, justifying the multiple. But if earnings normalize and the multiple compresses to a defense-cycle-trough P/E of 14-16x (the 1991-1995 trough range), the math is brutal: $12B normalized owner earnings × 15 P/E ÷ 1.34B shares ≈ $134 per share — 23% below current. If a downcycle drags normalized earnings to $9B, that's $100 — 42% below current. The 10-year average P/E of 24x is the right anchor, not 51x.

If I am right, the stock could be worth $100-115 within 3 years. Recovery happens — but from a much lower price than today.

Lollapalooza Bias Check

Examining biases active in me, the analyst, right now on RTX.

Authority bias — ACTIVE. Buffett's 2025 letter [1] [3] devotes substantial attention to Precision Castparts, an aerospace-components supplier whose end markets overlap heavily with RTX customers. Reading Buffett describe a recovering aerospace cycle creates a halo that subtly biases me toward bullishness on RTX. I should remember that PCC is a components business with different economics than RTX's prime-contractor model, and Buffett's commentary is post-mortem on a business he already owns, not a current buy signal at any price.

Recency bias — ACTIVE. The Ukraine war (2022-present), Israel-Hamas-Iran exchanges (2023-2025), and Pacific tensions are recent and salient. They make defense replenishment feel like a permanent regime. Historically, defense cycles always feel permanent at the peak. The 1986 Reagan buildup felt permanent; by 1995, real defense spending was 35% lower. Recency is biasing me toward over-extrapolating the current order book into perpetuity.

Anchoring — ACTIVE. I am anchored to the scorecard's IV range ($107-192) and base IV of $151. The model that produced these is deterministic Python with assumptions about maintenance capex and discount rates that may not hold in a downcycle. Anchoring to the model's central estimate makes the $174 price feel 'only 15% over' rather than 'inside the modeling noise band.' For a cyclical business at peak earnings, the IV uncertainty is wider than the model suggests.

Commitment-and-consistency bias — ACTIVE. I have to deliver an analysis with a recommendation. There is psychological pressure to make a 'call' rather than the genuinely correct answer of 'wait.' I should resist the urge to stretch the math to support 'Buy' or 'Sell' when 'Hold' or 'Avoid here, accumulate lower' is the honest answer.

Social proof — MILD. Defense names are widely held by quality-quant managers (e.g., Akre, Ruane Cunniff in the past, Polen). Their ownership creates a mild authority halo. I should ignore their positioning.

Confirmation bias — ACTIVE. Once I formed the thesis 'wide moat at wrong price,' I started reading every data point through that lens. Specifically, I have been quick to discount the bull case on aftermarket pricing power without stress-testing it.

Inactive: deprival super-reaction, incentive-caused bias. I have no position and no compensation tied to this call.

Net effect. The active biases are mostly bullish (authority, recency, social proof) — meaning my honest recommendation should probably be slightly more cautious than my instinct. That nudges the call from 'Hold' toward 'Avoid here / accumulate below $130.'

10-Year Outlook

Will RTX in 2036 be the same fundamental business it is today? Largely yes. Commercial aircraft built with Pratt and Collins content fly for 25-30 years, so today's installed base remains the primary aftermarket revenue source through the entire forecast window. The next-gen narrowbody decision (Boeing's 757 replacement, Airbus's A320neo successor) likely arrives within the decade and could shift competitive position — but not the underlying business model. Defense will still be characterized by long-life programs, ITAR/clearance moats, and government monopsony pricing. The fundamental shape persists.

Will the customer base be larger? Probably yes. Global air-traffic growth (~3-4% annual), driven primarily by Asia-Pacific middle-class formation, expands the addressable installed base. Allied defense budgets are structurally higher post-2022, and even a partial reversion still leaves the baseline elevated versus 2010-2020. Roughly 80% of NATO members now meet the 2% GDP threshold; Japan, South Korea, Australia, and Poland have committed to durable increases. Net: more aircraft, more allied missile inventories, more aftermarket lanes than today.

Will profit per customer be higher? Uncertain. Commercial aftermarket pricing has historically grown at 3-5%/year above inflation, but used-serviceable-material adoption, airline MRO consortia, and PMA (parts manufacturer approval) parts erosion are real headwinds. Defense margins are capped by DCMA cost-recovery rules and by Congressional pressure on profit caps in any administration. The honest answer is probably flat to modestly up in real terms, not expanding meaningfully on a per-unit basis.

Will the moat be wider? Probably similar to today. Certification, security clearance, and installed-base barriers compound modestly with each new platform win. Counter-pressures: Chinese aerospace (COMAC C919, CR929) catching up in non-Western markets, hypersonics disrupting traditional missile categories, autonomous-systems primes (Anduril, Shield AI) pressuring legacy missile and counter-drone contracts. Net stable, not widening.

Single biggest threat: a major DoD acquisition reform that recompetes legacy sole-source missile programs, combined with a peace-dividend budget cut after a Ukraine ceasefire and a Pacific de-escalation. Probability is low but not negligible (15-20% over a decade).

The business model is durable; the price and the cycle position are where my doubt lives. I have HIGH confidence the franchise persists; MEDIUM confidence in earnings trajectory; LOW confidence the current multiple persists.

CONFIDENCE: medium

Position Guidance

• Recommendation: Hold (Avoid here; accumulate below $130)
• Conviction: medium
• Target buy price: $130 (15% below base IV of $151; provides margin of safety)
• Target trim price: $192 (at or above bull-case IV of $191.81 — even optimistic scenarios are fully priced)
• Position sizing: If acquired in target buy zone, position can scale to 3-5% of portfolio given wide-moat franchise and $230B+ backlog visibility. Cap at 5% — defense-cycle exposure and GTF tail risk preclude treating this as a top-conviction compounder. New money at $174 is not justified; existing holders without a tax cost may consider trimming toward 50% of full target weight given Px/IV of 1.15.